Pharma
Cadila Healthcare Jun Q1 net profit up 50 pc at Rs 454 cr
NE BUSINESS BUREAU NEW DELHI, AUG 5 Drug manufacturing firm Cadila Healthcare on Wednesday reported a 49.53 per cent rise...
Read more
Sun Pharma launches FluGuard (Favipiravir) in India at Rs. 35 per tablet
NE NEWS SERVICE MUMBAI, AUG 4 Sun Pharmaceutical Industries Limited announced that it has launched FluGuard (Favipiravir 200 mg) at...
Read more
US generics business to continue its growth momentum: Cadila Healthcare
NE BUSINESS BUREAU NEW DELHI, AUG 2 Pharma firm Cadila Healthcare is bullish about its growth momentum in the United...
Read more
Mylan gets DCGI nod for Pretomanid, treatment for highly drug-resistant forms of tuberculosis
NE BUSINESS BUREAU NEW DELHI, AUG 2 Mylan on Saturday announced that the Drug Controller General of India (DCGI) has...
Read more
Zydus Cadila gets tentative nod from USFDA to market Parkinson’s disease drug
NE BUSINESS BUREAU NEW DELHI, AUGUST 1 Drug firm Zydus Cadila on Saturday said it has received a tentative nod...
Read more
Q1 results: Zydus Wellness net profit up 11 pc at Rs 89 cr
NE BUSINESS BUREAU NEW DELHI, JULY 31 Zydus group firm Zydus Wellness on Friday reported a 10.94 percent rise in...
Read more
Q1 result: Torrent Pharma net profit up 49 pc to Rs 321 cr
NE BUSINESS BUREAU NEW DELHI, JULY 30 Drug firm Torrent Pharmaceuticals on Thursday reported a 48.61 percent rise in its...
Read more
Alembic Pharma gets board approval to raise up to Rs 1,000 cr via QIP
NE BUSINESS BUREAU NEW DELHI, JULY 27 Alembic Pharmaceuticals on Monday said its board has given an approval to raise...
Read more
Mylan launches Remdesivir’s generic version ‘Desrem’
NE BUSINESS BUREAU AHMEDABAD, JULY 26 Mylan, a global pharmaceutical company, announced the commercial launch of its Remdesivir under the...
Read more
TN rejects Sun Pharma’s expansion plan near bird sanctuary, informs HC
NE LEGAL BUREAU CHENNAI, JULY 24 The Madras High Court was on Friday informed by the Tamil Nadu government that...
Read more
